Pharmaceutical equipment enterprises need to build "hard core technology" to win market trust

[market analysis of chinapharma.com] after removing the caps of "cheap", "simple operation" and "convenient maintenance", many pharmaceutical equipment products that rely on imitation and low-level repeated production are instantly "cool" According to the industry, products with real strength should return to the product itself, build "hard core technology", pharmaceutical equipment products with high added value, improve the ability of independent innovation, so as to further gain the hearts of users and win market trust "The technical strength of a company determines its development trend Without R & D technology, it is easy to be eliminated by the market." Industry insiders said that at present, China's pharmaceutical equipment industry is in the middle and low-end development stage, with products mainly produced repeatedly, weak core technology and few enterprises with R & D strength In recent years, with the rapid development of pharmaceutical industry, as well as the reconstruction of market pattern As the pharmaceutical equipment industry ushers in the development opportunity period, the industry concentration continues to improve, and the market competition is increasingly fierce In the context of the continuous improvement of equipment requirements in the pharmaceutical industry, domestic pharmaceutical equipment enterprises have to strengthen technical input and product innovation Pharmaceutical equipment is the equipment that directly contacts with drugs and is the key to ensure the efficiency, quality and safety of drug production If there are quality defects such as instability in pharmaceutical equipment, it will directly affect the quality of drugs and endanger the life safety of patients It is reported that at present, countries all over the world have set strict standards for pharmaceutical equipment, especially in developed countries and regions such as the United States, the United Kingdom and the European Union In addition, pharmaceutical equipment belongs to high-tech, high-difficulty and high-risk equipment, with high technical threshold and long-term monopoly of core technology by international giants Although the scale and market demand of pharmaceutical equipment in China are very large, the development of pharmaceutical equipment industry and pharmaceutical industry is seriously affected by the late start of the industry and the long-term control of core technology In recent years, with the medical equipment being included in the national strategic planning, as well as the establishment and improvement of relevant standards, the pharmaceutical equipment industry and pharmaceutical industry are expected to usher in a new round of breakthrough development In this context, some pharmaceutical equipment enterprises with R & D strength mainly focus on hard core technology and strengthen the ability of independent innovation For example, truking science and technology has spent more than ten years to tackle key problems in production, learning, research and application, invested a lot of R & D funds, completed more than 10 major national, local and enterprise projects, and achieved a leap forward development from being controlled by people to independent innovation and internationally For example, relying on strong R & D innovation and achievement transformation capabilities, DFL has long focused on R & D and technical reserves At present, DFL has owned and mastered the core technology of freeze-drying system industry, and has successfully developed and put into production the core equipment of freeze-drying system, such as liquid nitrogen freeze-drying machine, automatic feeding and unloading system and bacteria free isolation device The industry said that the key core technology innovation of domestic pharmaceutical equipment can not be separated from the support of policies and other aspects, so in the development process of domestic pharmaceutical equipment industry, the state needs to pay attention to and encourage this At present, the overall core technology level of the pharmaceutical equipment industry is quite different from that of European and American countries, but under the background of favorable innovation environment and gradual development, as well as a large number of capital influx and the return of overseas talents, the domestic pharmaceutical equipment industry is expected to usher in a new round of change, and the enterprises with capital strength and strong R & D and innovation ability have more advantages In addition, after the market baptism of fake and inferior products, users are more cautious and objective when purchasing pharmaceutical equipment In addition to the emphasis on hard core technology, product appearance, humanized design, comprehensive performance, after-sales service and other indicators will become an important basis for users to evaluate product value.